The radical scavenger edaravone prevents oxidative neurotoxicity induced by peroxynitrite and activated microglia
- PMID: 15695167
- DOI: 10.1016/j.neuropharm.2004.10.002
The radical scavenger edaravone prevents oxidative neurotoxicity induced by peroxynitrite and activated microglia
Abstract
The free radical scavenger edaravone has been used as an anti-oxidative agent in acute ischemic brain disorders. We examined the effect of edaravone on the production of nitric oxide (NO), reactive oxygen species (ROS) and proinflammatory cytokines by activated microglia, and we also examined its neuroprotective role in cortical neuronal cultures oxidatively stressed by the peroxynitrite donor N-morpholinosydnonimine (SIN-1) or activated microglia. Edaravone significantly suppressed the production of NO and ROS by activated microglia, though it did not suppress production of inflammatory cytokines. In addition, edaravone significantly suppressed neuronal cell death and dendrotoxicity induced by either SIN-1 or activated microglia in a dose-dependent manner. These results suggest that edaravone may function as a neuroprotective agent counteracting oxidative neurotoxicity arising from activated microglia, as occurs in either inflammatory or neurodegenerative disorders of the central nervous system.
Similar articles
-
Protective effect of the radical scavenger edaravone against methamphetamine-induced dopaminergic neurotoxicity in mouse striatum.Eur J Pharmacol. 2006 Aug 7;542(1-3):92-9. doi: 10.1016/j.ejphar.2006.05.012. Epub 2006 May 17. Eur J Pharmacol. 2006. PMID: 16784740
-
Interferon-beta is neuroprotective against the toxicity induced by activated microglia.Brain Res. 2007 Nov 7;1179:140-6. doi: 10.1016/j.brainres.2007.08.055. Epub 2007 Sep 4. Brain Res. 2007. PMID: 17905201
-
The free-radical scavenger, edaravone, augments NO release from vascular cells and platelets after laser-induced, acute endothelial injury in vivo.Platelets. 2006 May;17(3):201-6. doi: 10.1080/09537100500444063. Platelets. 2006. PMID: 16702048
-
[Research and development of the free radical scavenger edaravone as a neuroprotectant].Yakugaku Zasshi. 2004 Mar;124(3):99-111. doi: 10.1248/yakushi.124.99. Yakugaku Zasshi. 2004. PMID: 15049127 Review. Japanese.
-
Beyond neurological disease: new targets for edaravone (Review).Int J Mol Med. 2011 Dec;28(6):899-906. doi: 10.3892/ijmm.2011.795. Epub 2011 Sep 15. Int J Mol Med. 2011. PMID: 21922128 Review.
Cited by
-
Hyperbaric oxygen therapy improves local microenvironment after spinal cord injury.Neural Regen Res. 2014 Dec 15;9(24):2182-8. doi: 10.4103/1673-5374.147951. Neural Regen Res. 2014. PMID: 25657740 Free PMC article.
-
The neuroprotective effects of milk fat globule-EGF factor 8 against oligomeric amyloid β toxicity.J Neuroinflammation. 2012 Jun 28;9:148. doi: 10.1186/1742-2094-9-148. J Neuroinflammation. 2012. PMID: 22742657 Free PMC article.
-
A critical assessment of edaravone acute ischemic stroke efficacy trials: is edaravone an effective neuroprotective therapy?Expert Opin Pharmacother. 2010 Jul;11(10):1753-63. doi: 10.1517/14656566.2010.493558. Expert Opin Pharmacother. 2010. PMID: 20491547 Free PMC article. Review.
-
FGF-2 released from degenerating neurons exerts microglial-induced neuroprotection via FGFR3-ERK signaling pathway.J Neuroinflammation. 2014 Apr 16;11:76. doi: 10.1186/1742-2094-11-76. J Neuroinflammation. 2014. PMID: 24735639 Free PMC article.
-
Hyperthermia influences excitatory and inhibitory amino acid neurotransmitters in the central nervous system. An experimental study in the rat using behavioural, biochemical, pharmacological, and morphological approaches.J Neural Transm (Vienna). 2006 Apr;113(4):497-519. doi: 10.1007/s00702-005-0406-1. J Neural Transm (Vienna). 2006. PMID: 16550328
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
